©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2011; 17(48): 5310-5316
Published online Dec 28, 2011. doi: 10.3748/wjg.v17.i48.5310
Published online Dec 28, 2011. doi: 10.3748/wjg.v17.i48.5310
Table 1 Patient demographics and tumor characteristics in the test and validation sets n (%)
| Characteristics | Test set | Validation set |
| Total number of patients | 249 (100) | 15 (100) |
| Median age (yr, ranges) | 55, 24-81 | 56, 33-74 |
| Sex | ||
| Male | 177 (71.1) | 11 (73.3) |
| Female | 72 (28.9) | 4 (26.7) |
| Low margin from anal verge (cm) | ||
| ≤ 5 | 187 (75.1) | 12 (80) |
| > 5 | 62 (24.9) | 3 (20) |
| Histological type | ||
| Adenocarcinoma | 238 (95.6) | 14 (93.3) |
| Mucinous | 9 (3.6) | 1 (6.7) |
| Signet ring cell | 2 (0.8) | 0 (0) |
| Surgery | ||
| Abdominal-perineal resection | 37 (14.9) | 0 (0) |
| Low anterior resection | 208 (83.5) | 14 (93.3) |
| Hartmann’s operation | 4 (1.6) | 1 (6.7) |
| Chemotherapy regimen1 | ||
| FL group | 200 (80.6) | 9 (60) |
| Capecitabine group | 48 (19.4) | 6 (40) |
| Median interval to surgery (d, ranges) | 55, 26-120 | 54, 41-78 |
- Citation: Park CH, Kim HC, Cho YB, Yun SH, Lee WY, Park YS, Choi DH, Chun HK. Predicting tumor response after preoperative chemoradiation using clinical parameters in rectal cancer. World J Gastroenterol 2011; 17(48): 5310-5316
- URL: https://www.wjgnet.com/1007-9327/full/v17/i48/5310.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i48.5310